Cocrystal Pharma Profile

USD 0.0001  0.0019%

Acquisition by Raymond Schinazi of 1851851 shares of Cocrystal Pharma subject to Rule 16b-3

Cocrystal Pharma Inc insider trading alert for grant of 8% convertible note by Raymond Schinazi, the corporate stakeholder, on December 8, 2017. This event was filed by Cocrystal Pharma Inc with SEC on 2017-12-08. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Cocrystal Pharma Summary

Cocrystal Pharma Inc (COCP) is traded on OTC Market in USA. It is located in 1860 Montreal Road and employs 18 people. The company currently falls under 'Small-Cap' category with current market capitalization of 100.74 M. Cocrystal Pharma Inc has 24.27 M outstanding shares. COCRYSTAL PHARMA currently holds about 1.34 M in cash with (7.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Check Cocrystal Pharma Probability Of Bankruptcy

Ownership Allocation (%)

Cocrystal Pharma Inc Risk Profiles

Key Fundamentals

Cocrystal Pharma Against Markets

Current Ratings

Cocrystal Pharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 51% 
Equity ratings for Cocrystal Pharma Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Cocrystal Pharma, Inc., a clinical stage biotechnology company, focuses on the discovery and development of antiviral therapeutics for the treatment of serious andor chronic viral diseases. Cocrystal Pharma, Inc. was founded in 2007 and is headquartered in Tucker, Georgia. Cocrystal Pharma operates under Drug Related Products classification in USA and traded on OTC Market exchange. It employs 18 people. more
NameCocrystal Pharma Inc
CEO and DirectorJeffrey MecklerView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address1860 Montreal Road
ExchangeOTC Market
Contact Number678 892 8800
CurrencyUSD - US Dollar

Did you try this?

Run Money Flow Index Now

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
Hide  View All  NextLaunch Money Flow Index

Diversify with Cocrystal Pharma Inc

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Cocrystal Pharma Inc to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Cocrystal Pharma Corporate Directors
Raymond Schinazi Director, CFA
Steven Rubin Director
Phillip Frost Director